Novo Nordisk Faces a Two-Pronged Test: Quarterly Results and a Pivotal FDA Decision
The Danish pharmaceutical giant Novo Nordisk enters a defining stretch this week, with its second-quarter earnings due on…
Novo Nordisk’s Technical Rebound Faces Its Toughest Test: The Q2 Earnings Report
Novo Nordisk’s shares have clawed back 13% over the past month, pushing the stock back above its 200-day…
BayWa’s Rescue Race: A Share Bounce from Agrana and Berlin, but the Real Test Comes This Autumn
BayWa shares closed Friday at €10.90, notching a 4.31% gain that briefly interrupted a bleak stretch. The move,…
Novo Nordisk’s Rally Faces a Test: Medicare Tailwinds Meets Analyst Caution and a Billion-Dollar P
The past month has brought some much-needed relief to Novo Nordisk shareholders. After shedding nearly a third of…
Oral Wegovy’s UK Rollout Puts Novo Nordisk’s Pivot to the Pill to the Test
Novo Nordisk’s long-anticipated shift from injection to tablet enters its most public phase this week, with the oral…
European Lithium’s Merger Countdown: Cash Condition, Greenland Test, and a 19% Monthly Slide
European Lithium is navigating a complex web of deadlines as it pushes toward a transformative merger with Critical…
PH, Denmark to test modern fishing tech in local waters
THE Bureau of Fisheries and Aquatic Resources (BFAR) has partnered with the Danish Fishing Technology Cluster to pilot…
1666 Amsterdam hoped for a glorious welcome, but faces backlash for ‘oversight’
ⓘ Steam One of the characters from 1666 Amsterdam. Panache Digital Games announced their first game, 1666 Amsterdam,…
Wegovy Pill’s Gulf Debut Puts Novo Nordisk’s Global Ambitions to the Test Amid Competitive Press
Novo Nordisk expands oral Wegovy to UAE, targeting a vast untapped obesity market. Shares remain under pressure from…
Novo Nordisk’s Next Hurdle: August Earnings Will Test Whether Pill Uptake Can Counter a 65% Canadi
Novo Nordisk shares rebound 10% but remain down 15% YTD. Generic Ozempic competition looms in Canada, while oral…
A$24 Million Cash Squeeze and Greenland Permit Delay Test Merger Momentum
Takeover deal with Critical Metals advances amid cash shortfall and regulatory delays at Wolfsberg and Tanbreez projects, while…
Greenland Approvals and a $24 Million Cash Gap Test the Rally
European Lithium stock rallies 205% YTD, but merger with Critical Metals faces A$24M cash shortfall and exclusivity ban…